Last updated on September 2018

Patients are needed to participate in a clinical research study evaluating Onabotulinumtoxin A for the treatment of Interstitial Cystitis


Brief description of study

The purpose of this research study is to identify the optimal usage of Onabotulinumtoxin A in interstitial cystitis. Onabotulinumtoxin A, more commonly known by the trade name Botox, is a medication that comes from the bacteria Clostridium botulinum. It works by blocking the release of the neurotransmitter acetylcholine(a chemical messenger that carries signals between nerve cells and other cells in the body). Blocking that neurotransmitter results in decreased muscle activity.

Detailed Study Description

The purpose of this study is to evaluate the efficacy of intravesicular Onabotulinumtoxin A injections for the treatment of interstitial cystitis (IC). Specifically, we hypothesize that trigonal Onabotulinumtoxin A injections is an effective treatment for IC and will result in more subjective and objective symptom relief than posterior wall Onabotulinumtoxin A injections.

Clinical Study Identifier: NCT02297100

Contact Investigators or Research Sites near you

Start Over

Wake Forest School of Medicine
Winston-Salem, NC United States